Gene · 445
Papers3,531
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,531
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Glutamine synthetase limits β-catenin-mutated liver cancer growth by maintaining nitrogen homeostasis and suppressing mTORC1. | J Clin Invest | 2022 | 36256480 | PubTator, text mining | PubMed |
| A new CCCH-type zinc finger-related lncRNA signature predicts the prognosis of clear cell renal cell carcinoma patients. | Front Genet | 2022 | 36246657 | PubTator, text mining | PubMed |
| A comprehensive transcriptomic comparison of hepatocyte model systems improves selection of models for experimental use. | Commun Biol | 2022 | 36241695 | PubTator, text mining | PubMed |
| Multi-Omics Analysis Revealed a Significant Alteration of Critical Metabolic Pathways Due to Sorafenib-Resistance in Hep3B Cell Lines. | Int J Mol Sci | 2022 | 36233276 | PubTator, text mining | PubMed |
| On the Relevance of Soft Tissue Sarcomas Metabolic Landscape Mapping. | Int J Mol Sci | 2022 | 36232732 | PubTator, text mining | PubMed |
| Enhancement of anti-tumor activity in melanoma using arginine deiminase fused with 30Kc19α protein. | Appl Microbiol Biotechnol | 2022 | 36227339 | PubTator, text mining | PubMed |
| Targeted metabolomic profiles of serum amino acids and acylcarnitines related to gastric cancer. | PeerJ | 2022 | 36221263 | PubTator, text mining | PubMed |
| Predicting the disease severity in male individuals with ornithine transcarbamylase deficiency. | Ann Clin Transl Neurol | 2022 | 36217298 | PubTator, text mining | PubMed |
| Comparing the effects of olfactory-based sensory stimulation and board game training on cognition, emotion, and blood biomarkers among individuals with dementia: A pilot randomized controlled trial. | Front Psychol | 2022 | 36204759 | PubTator, text mining | PubMed |
| Glaucoma and Alzheimer: Neurodegenerative disorders show an adrenergic dysbalance. | PLoS One | 2022 | 36201426 | PubTator, text mining | PubMed |
| Mitochondrial metabolic determinants of multiple myeloma growth, survival, and therapy efficacy. | Front Oncol | 2022 | 36185202 | PubTator, text mining | PubMed |
| Immuno-digital invasive cleavage assay for analyzing Alzheimer's amyloid ß-bound extracellular vesicles. | Alzheimers Res Ther | 2022 | 36184615 | PubTator, text mining | PubMed |
| ASS1 regulates immune microenvironment via CXCL8 signaling in ovarian cancer. | Biochem Biophys Res Commun | 2022 | 36182868 | PubTator, text mining | PubMed |
| Preclinical evidence of a direct pro-survival role of arginine deprivation in multiple myeloma. | Front Oncol | 2022 | 36172163 | PubTator, text mining | PubMed |
| Therapeutic implications of mitochondrial stress-induced proteasome inhibitor resistance in multiple myeloma. | Sci Adv | 2022 | 36170375 | PubTator, text mining | PubMed |
| Building in vitro models of the brain to understand the role of APOE in Alzheimer's disease. | Life Sci Alliance | 2022 | 36167428 | PubTator, text mining | PubMed |
| Modelling urea cycle disorders using iPSCs. | NPJ Regen Med | 2022 | 36163209 | PubTator, text mining | PubMed |
| A time-course transcriptome analysis of wax gourd fruit development reveals predominant genes regulating taste and nutrition. | Front Plant Sci | 2022 | 36161022 | PubTator, text mining | PubMed |
| Small extracellular vesicles and liver diseases: From diagnosis to therapy. | World J Hepatol | 2022 | 36158910 | PubTator, text mining | PubMed |
| Metabolomic comparison followed by cross-validation of enzyme-linked immunosorbent assay to reveal potential biomarkers of diabetic retinopathy in Chinese with type 2 diabetes. | Front Endocrinol (Lausanne) | 2022 | 36157454 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/445/papers?page=32